Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine.
Michael Belanich(The University of Texas MD Anderson Cancer Center), Daniel B. Yarosh(The University of Texas MD Anderson Cancer Center), Stephen W. Coons(University of Maryland, Baltimore), Kurt A. Jaeckle(Jacksonville College), Ben Li(Jiangsu Province Hospital), Jeannie Kibitel(Pediatrics and Genetics), Terri Randall(Pediatrics and Genetics), Susan Schulman(The University of Texas MD Anderson Cancer Center), Patricia Wasserman(Albert Einstein College of Medicine), Marc L. Citron(Northwell Health), Michael D. Prados(UCSF Helen Diller Family Comprehensive Cancer Center), D J Rector(Fred Hutch Cancer Center), A White(Northwell Health), Monica Pastor(Pediatrics and Genetics), William Shapiro(St. Joseph's Hospital and Medical Center), Lori Alas(Pediatrics and Genetics), Harmon J. Eyre(American Cancer Society), Denise Guerra(Pediatrics and Genetics)
PubMed
February 15, 1996
Cited by 246
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
American Cancer Society Guidelines for the Early Detection of Cancer
|CA A Cancer Journal for Clinicians|2002|1.6k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
|New England Journal of Medicine|2016|1k